United Therapeutics (UTHR) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $7.16.
- United Therapeutics' EPS (Weighted Average and Diluted) rose 1205.01% to $7.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $26.41, marking a year-over-year increase of 1613.9%. This contributed to the annual value of $24.64 for FY2024, which is 2438.79% up from last year.
- Per United Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $7.16 for Q3 2025, which was up 1205.01% from $6.41 recorded in Q2 2025.
- In the past 5 years, United Therapeutics' EPS (Weighted Average and Diluted) registered a high of $7.16 during Q3 2025, and its lowest value of $0.61 during Q1 2021.
- Over the past 5 years, United Therapeutics' median EPS (Weighted Average and Diluted) value was $5.03 (recorded in 2022), while the average stood at $4.72.
- Per our database at Business Quant, United Therapeutics' EPS (Weighted Average and Diluted) tumbled by 8044.87% in 2021 and then skyrocketed by 72459.02% in 2022.
- United Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at $2.34 in 2021, then grew by 13.25% to $2.65 in 2022, then soared by 63.4% to $4.33 in 2023, then soared by 43.47% to $6.21 in 2024, then rose by 15.25% to $7.16 in 2025.
- Its last three reported values are $7.16 in Q3 2025, $6.41 for Q2 2025, and $6.63 during Q1 2025.